EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retained Metabolic Flexibility of the Failing Human Heart

William D Watson iD, Peregrine G Green, Andrew J M Lewis iD, Per Arvidsson iD, Giovanni Luigi De Maria, Håkan Arheden iD, Einar Heiberg, William T Clarke iD, Christopher T Rodgers iD, Ladislav Valkovič iD, Stefan Neubauer iD, Neil Herring iD und 1 weitere

Circulation · 11.07.2023 · 148 (2) · 109-123

DOI: 10.1161/circulationaha.122.062166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 11.07.2023. Verfasst von William D Watson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Centre for Magnetic Resonance Research (W.D.W., P.G.G., A.J.M.L., P.A., L.V., S.N., O.J.R.), University of Oxford, UK. Hauptthemen laut MEDLINE: Heart Failure, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The failing heart is traditionally described as metabolically inflexible and oxygen starved, causing energetic deficit and contractile dysfunction. Current metabolic modulator therapies aim to increase glucose oxidation to increase oxygen efficiency of adenosine triphosphate production, with mixed results.

Methods

To investigate metabolic flexibility and oxygen delivery in the failing heart, 20 patients with nonischemic heart failure with reduced ejection fraction (left ventricular ejection fraction 34.9±9.1) underwent separate infusions of insulin+glucose infusion (I+G) or Intralipid infusion. We used cardiovascular magnetic resonance to assess cardiac function and measured energetics using phosphorus-31 magnetic resonance spectroscopy. To investigate the effects of these infusions on cardiac substrate use, function, and myocardial oxygen uptake (MV o 2 ), invasive arteriovenous sampling and pressure–volume loops were performed (n=9).

Results

At rest, we found that the heart had considerable metabolic flexibility. During I+G, cardiac glucose uptake and oxidation were predominant (70±14% total energy substrate for adenosine triphosphate production versus 17±16% for Intralipid; P =0.002); however, no change in cardiac function was seen relative to basal conditions. In contrast, during Intralipid infusion, cardiac long-chain fatty acid (LCFA) delivery, uptake, LCFA acylcarnitine production, and fatty acid oxidation were all increased (LCFA 73±17% of total substrate versus 19±26% total during I+G; P =0.009). Myocardial energetics were better with Intralipid compared with I+G (phosphocreatine/adenosine triphosphate 1.86±0.25 versus 2.01±0.33; P =0.02), and systolic and diastolic function were improved (LVEF 34.9±9.1 baseline, 33.7±8.2 I+G, 39.9±9.3 Intralipid; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureVentricular Dysfunction, LeftHumansStroke VolumeEnergy MetabolismVentricular Function, LeftMyocardiumAdenosine TriphosphateFatty AcidsGlucoseOxygen

Stichwörter der Autor:innen

adenosine triphosphateheart failuremagnetic resonance spectroscopymetabolism

Substanzen

Adenosine TriphosphateFatty AcidsGlucoseOxygen

Autor:innen und Institutionen

  • Oxford Centre for Magnetic Resonance Research (W.D.W., P.G.G., A.J.M.L., P.A., L.V., S.N., O.J.R.), University of Oxford, UK.
  • Department of Cardiovascular Medicine (W.D.W.), University of Cambridge, UK.
  • Department for Physiology, Anatomy and Genetics (P.G.G., N.H.), University of Oxford, UK.
  • Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden (P.A., H.A., E.H.).
  • Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, UK (G.L.D.M.).
  • Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences (W.T.C.), University of Oxford, UK.

ORCID-Profile: William D Watson, Andrew J M Lewis, Per Arvidsson, Håkan Arheden, William T Clarke, Christopher T Rodgers, Ladislav Valkovič, Stefan Neubauer, Neil Herring, Oliver J Rider

Förderung

  • British Heart Foundation

Zitieren

APA

Watson, W. D., Green, P. G., Lewis, A. J. M., Arvidsson, P., De Maria, G. L., Arheden, H., Heiberg, E., Clarke, W. T., Rodgers, C. T., Valkovič, L., Neubauer, S., Herring, N., & Rider, O. J. (2023). Retained Metabolic Flexibility of the Failing Human Heart. Circulation, 148(2), 109-123. https://doi.org/10.1161/circulationaha.122.062166

Vancouver

Watson WD, Green PG, Lewis AJM, Arvidsson P, De Maria GL, Arheden H, et al. Retained Metabolic Flexibility of the Failing Human Heart. Circulation. 2023;148(2):109-123. doi:10.1161/circulationaha.122.062166

BibTeX
@article{Watson2023,
  author = {Watson, William D and Green, Peregrine G and Lewis, Andrew J M and Arvidsson, Per and De Maria, Giovanni Luigi and Arheden, Håkan and Heiberg, Einar and Clarke, William T and Rodgers, Christopher T and Valkovič, Ladislav and Neubauer, Stefan and Herring, Neil and Rider, Oliver J},
  title = {Retained Metabolic Flexibility of the Failing Human Heart},
  journal = {Circulation},
  year = {2023},
  volume = {148},
  number = {2},
  pages = {109--123},
  doi = {10.1161/circulationaha.122.062166}
}
Kostenlos starten →